2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Print

Mini-Oral Session

[MO7] Mini-Oral Session 7　Rare Cancer / Cancer of Unknown Primary 1（Bone and soft tissue）
【E】

Thu. Feb 17, 2022 3:00 PM - 3:40 PM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Kohichi Takada（Department of Medical Oncology, Sapporo Medical University School of Medicine），Kazuki Sudo（Department of Medical Oncology, National Cancer Center）

[MO7-1] Effect of Neoadjuvant Therapies on Soft Tissue Sarcomas with Tail-like Lesions: A Multicenter Retrospective Study

○Hisaki Aiba1, Kunihro Ikuta2, Kunihiro Asanuma3, Katsuhisa Kawanami4, Satoshi Tsukushi5, Akihiko Matsumine6, Daisuke Ishimura7, Akihito Nagano8, Yoji Sido9, Eiji Kozawa10, Kenji Yamada11, Juniji Wasa12, Kimura Hiroaki1, Takao Sakai1, Hideki Murakami1, Tomohisa Sakai2, Tomoki Nakamura3, Yoshihiro Nishida2,13 (1.Department of Orthpaedic Surgery, Nagoya City University, 2.Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 3.Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, 4.Department of Orthopaedic Surgery, Aichi Medical University School of Medicine, 5.Division of Orthopaedic Surgery, Aichi Cancer Center Hospital, 6.Department of Orthopaedics and Rehabilitation Medicine, Faculty of Medical Sciences University of Fukui, 7.Department of Orthopaedic Surgery, Fujita Medical University, 8.Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, 9.Department of Orthopaedic Surgery, Hamamatsu Medical University, 10.Department of Orthopaedic Surgery, Nagoya Memorial Hospital, 11.Department of Orthopedic Oncology, Okazaki City Hospital, 12.Division of Orthopaedic Oncology, Shizuoka Cancer Center Hospital, 13.Department of Rehabilitation, Nagoya University Hospital)

[MO7-3] A retrospective comparison of patients with sarcoma treated before and after new chemotherapeutic agent in Japan

○Toshio Kubo1, Takada Kenji2, Nishimura Jun2, Nakamura Keiichiro3, Nakata Eiji4, Toshiyuki Kunisada4, Maeda Yoshinobu5, Ozaki Toshifumi4, Tabata Masahiro1 (1.Center for Clinical Oncology, Okayama University Hospital, 2.Allergy and Respiratory Medicine, Okayama University Hospital, 3.Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 4.Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 5.Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)